Seeking Alpha

Amicus Therapeutics (FOLD -20.8%) finishes the day markedly lower after announcing earlier that...

Amicus Therapeutics (FOLD -20.8%) finishes the day markedly lower after announcing earlier that it will delay seeking regulatory approval for migalastat HCI, its experimental Fabry disease drug until the second half of next year.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs